Visit 1 | Visit 2 | Visit 3 | Visit 4 | Visit 5 | Visit 6 | Visit 7 | |
---|---|---|---|---|---|---|---|

Time since randomization^{*} (months) | Baseline | Baseline | Baseline | 6 | 6 | 12 | 12 |

Resting BP | A, B, C | A, B, C | A, B, C | A, B, C | A, B, C | A, B, C | A, B, C |

Fasting lipid profile | A, B, C | A, B, C | A, B, C | A, B, C | A, B, C | A, B, C | |

HbA1C | A, B, C | A, B, C | A, B, C | ||||

CVD history | A, B, C | ||||||

Interval CVD history | A, B, C | A, B, C | |||||

Medication review | A, B, C | A, B, C | A, B, C | ||||

Medication adherence | A, B, C | B | A, B, C | ||||

HRQL | A, B, C | A, B, C | A, B, C | ||||

Healthcare satisfaction | A, B, C | A, B, C | |||||

Health-related self-efficacy | A, B, C | B | B | ||||

Social network | A, B, C | B | A, B, C | ||||

SP qualities/involvement | A, B, C | B | A, B, C | ||||

Demographics | A, B, C | A, B, C | A, B, C |

Patient education session occurred during visit 3.

* Randomization occurred after visit 2.

BP, blood pressure; CVD, cardiovascular disease; HRQL, health-related quality of life; SP, support person; A, intervention group A; B, intervention group B; C, control group.